Corrigendum to "Canadian evidence-based guideline for frontline treatment of chronic lymphocytic leukemia: 2022 update" [Leukemia Research 125 (2023) 107016]
Leuk Res
.
2023 May:128:107073.
doi: 10.1016/j.leukres.2023.107073.
Epub 2023 Apr 3.
Authors
Carolyn Owen
1
,
Versha Banerji
2
,
Nathalie Johnson
3
,
Alina Gerrie
4
,
Andrew Aw
5
,
Christine Chen
6
,
Sue Robinson
7
Affiliations
1
Division of Hematology and Hematological Malignancies, Foothills Medical Centre, Calgary, AB T2N 4N2, Canada. Electronic address:
[email protected]
.
2
Department of Hematology and Medical Oncology, CancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada.
3
Department of Medicine, Jewish General Hospital, Montréal, QC H3T 1E2, Canada.
4
Division of Medical Oncology, Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC V5Z 4E6, Canada.
5
Division of Hematology, The Ottawa Hospital, Ottawa, Ontario K1Y 4E9, Canada.
6
Department of Medical Oncology, University of Toronto, and Princess Margaret Cancer Centre, Toronto, ON M5G 2C1, Canada.
7
Division of Hematology, Dalhousie University, and qeii Health Sciences Centre, Halifax, NS B3H 2Y9, Canada.
PMID:
37019803
DOI:
10.1016/j.leukres.2023.107073
No abstract available
Publication types
Published Erratum